Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07128628) titled 'A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease' on Aug. 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Bausch & Lomb Incorporated
Condition:
Dry Eye Disease
Intervention:
Drug: Lifitegrast/Perfluorohexyloctane Fixed Dose Combination
Drug: Lifitegrast
Drug: Perfluorohexyloctane
Drug: Vehicle
Drug: Vehicle
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: November 2025
Target Sample Size:...